Sign in
WithdrawnPhase 1

Intra-Arterial Neuroprotective Agents and Cold Saline in Ischemic Stroke Intervention

Key facts

Who runs it
Northwell Health
Where
Manhasset, United StatesSee the site
Trial code
Status
Withdrawn
Phase
Phase 1
Started
1 Jun 2021
Ended
Mar 2026
Type of study
Interventional
Treatments tested
  • Intra-arterial cold saline, minocycline, and magnesium
Record updated
6 April 2026
Why it stopped
it was very difficult to enroll in this acute population

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Male or female aged 18-90
  • Signed and dated informed consent and IRB form by the patient or legally authorized health care proxy
  • Diagnosis of acute ischemic stroke due to large vessel occlusion based on clinical and radiographic evidence as determined and documented by the Stroke Neurology team at Northshore University Hospital
  • Participants must meet criteria for intra-arterial thrombectomy as determined and documented by the Stroke Neurology and Interventional Neuroradiology attending physicians at Northshore University Hospital
  • Angiography must reveal a thromboembolism which is completely occluding flow within the intracranial portion of the internal carotid artery, the M1 or proximal M2 portions of the middle cerebral artery

Who cannot take part

  • Therapeutic anticoagulation prior to presentation
  • Patients with a known prior diagnosis of heart block or prior myocardial infarction (increased risk of adverse reaction to MgSO4)
  • Idiopathic intracranial hypertension
  • Known allergic reactions to contrast dye or components of minocycline (tetracycline) or magnesium sulfate
  • Renal insufficiency (creatinine > 2.5 mg/dL)
  • Severe hepatic functional impairment (AST > 10xULN, bilirubin > 5xULN)
  • Patients that do not otherwise meet criteria for endovascular intervention
  • Large vessel occlusion of the anterior cerebral artery, posterior circulation, or distal M2 portion of the middle cerebral artery
  • Recanalization of only TICI 0-2A
  • Pregnant or lactating women
  • Systemic lupus erythematosus

Where in United States

  • North Shore University HospitalManhasset, United States

About the trial

What the trial wants to find out

Ischemic stroke is the leading cause of long-term disability in the United States. Endovascular intervention with mechanical thrombectomy has become the standard of care for acute large vessel occlusion (LVO) stroke since multiple clinical trials demonstrated improved long-term clinical outcomes with treatment. However, despite high rates of successful vessel recanalization and thus reperfusion of ischemic brain tissue in current practice, many patients continue to suffer debilitating strokes and poor long-term functional outcome. Pharmacologic neuroprotection could potentially present a means of addressing this mismatch in radiologic vs. clinical outcomes by protecting and salvaging damaged brain tissue. Intra-arterial delivery of a cocktail of neuroprotective therapy at the time of endovascular reperfusion would provide immediate, targeted therapy directly to the damaged brain territory. Hypothermia, minocycline and magnesium can target multiple facets of the complex ischemic injury cascade, and have each demonstrated neuroprotection in multiple preclinical models. This is a phase I trial that aims to demonstrate safety and feasibility of administering cold saline, minocycline, and magnesium sulfate intra-arterially immediately after thrombectomy in stroke interventions.

The group in the trial

  • Intra-arterial neuroprotective substancesTreatment being tested

    Cold saline, minocycline, and magnesium sulfate to be infused intra-arterially immediately after thrombectomy via the internal carotid artery. A dose escalation design will be used, as described above in "Study Description."

    Treatment: Intra-arterial cold saline, minocycline, and magnesium

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Intra-Arterial Administration of Neuroprotective Agents and Cold Saline at Time of Recanalization for Acute Ischemic Stroke Due to Large Vessel Occlusion
Record updated
6 April 2026